Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy C Mandigo

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repairAyesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate CancerEmanuela Dylgjeri, Vishal Kothari, Ayesha A Shafi, et al.
Cancer Discovery|April 21, 2021
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced DiseaseAmy C Mandigo, Wei Yuan, Kexin Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic StrategiesEmanuela Dylgjeri, Christopher McNair, Jonathan F Goodwin, et al.
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repairAyesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate CancerEmanuela Dylgjeri, Vishal Kothari, Ayesha A Shafi, et al.
Cancer Discovery|April 21, 2021
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced DiseaseAmy C Mandigo, Wei Yuan, Kexin Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic StrategiesEmanuela Dylgjeri, Christopher McNair, Jonathan F Goodwin, et al.
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Pageof 2